Related Party Transactions |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 11. RELATED PARTY TRANSACTIONS The Company enters into transactions with related parties in the ordinary course of business. Related parties include the Company’s directors, executive officers, principal stockholders, and entities in which such individuals have a controlling financial interest. Scientific Advisory Board Member One of the Company’s co-founders and former director is a member of the Company’s Scientific Advisory Board and meets the criteria of a related party. The Company incurred expense of $0.1 million for advisory services provided in each of the three and six month periods ended June 30, 2026 and 2025. There were no amounts due to this related party as of June 30, 2026 or December 31, 2025. In May 2026, the Company terminated its agreement with this related party and does not expect to incur further expense under the arrangement. License Agreement Harvard meets the criteria of a related party resulting from the Company’s co-founders’ employment as professors in the Harvard Department of Molecular Pharmacology. Core intellectual property utilized by the Company is licensed from Harvard under the License Agreement described in Note 9, License Agreements. The Company incurred expense of $0.1 million related to the License Agreement during each of the three and six month periods ended June 30, 2026 and 2025. No amounts were due to Harvard related to the License Agreement as of June 30, 2026 or December 31, 2025. |